A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study

Table 2

Summary of screening tumor characteristic variables.

Variable	Level	Total (n = 24)
Breast cancer staging (overall)
	IA	12 (50%)
	IB	1 (4%)
	IIA	4 (17%)
	IIB	3 (13%)
	IIIA	2 (8%)
	IIIB	2 (8%)
# of nodes
	0	18 (75%)
	1	2 (12%)
	2	2 (8%)
	6	1 (4%)
	8	1 (4%)
History of prior cardiac events, previous diagnosis of hypertension, hypercholesterolemia, or diabetes?
	Missing	1 (4%)
	No	22 (92%)
	Yes	1 (4%)
Estrogen receptor
	Negative	4 (17%)
	Positive	20 (83%)
Progesterone receptor
	Negative	6 (25%)
	Positive	18 (75%)
Her2-neu (IHC)
	0	9 (38%)
	1	8 (33%)
	2	2 (8%)
	3	5 (21%)
Her2-neu (FISH)
	Negative	17 (71%)
	Positive	7 (29%)
ER/PR/Her2-neu
	Missing	1 (4%)
	ER+/PR+/HER2+	4 (17%)
	ER+/PR+/HER2−	13 (54%)
	ER+/PR−/HER2+	1 (4%)
	ER+/PR−/HER2−	1 (4%)
	ER−/PR−/HER2+	2 (8%)
	ER−/PR−/HER2−	2 (8%)
Grade
	1	3 (12%)
	2	10 (42%)
	3	11 (50%)
Location of primary breast tumor
	Bilateral	1 (4%)
	Left	12 (50%)
	Right	11 (46%)
Tumor size
	Median; (min, max)	1.5; (0.4, 3.8)